<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2225">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05132192</url>
  </required_header>
  <id_info>
    <org_study_id>PVT-LDLT-ANK</org_study_id>
    <nct_id>NCT05132192</nct_id>
  </id_info>
  <brief_title>Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis</brief_title>
  <official_title>Outcomes of Surgical Strategies for Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elvan Onur Kirimker</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ankara Guven Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Data of demographic, clinical, laboratory and imaging studies of living donor liver&#xD;
      transplantation (LDLT) recipients from two transplant centers were collected. Survival and&#xD;
      morbidity rates between patients with and without portal vein thrombosis (PVT) were compared.&#xD;
      Risk factors of mortality in the setting of PVT were identified. Intraoperative portal flow&#xD;
      measurements were compared before and after portal flow restoration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LDLTs performed in two experienced centers (Ankara University Ibn-i Sina Hospital and Ankara&#xD;
      Güven Hospital) between January 2013 and February 2020 were evaluated and included in the&#xD;
      cohort study. Deceased donor liver transplants and pediatric transplants (deceased or living)&#xD;
      were excluded from the study.&#xD;
&#xD;
      Data relating to this study including patient history, preoperative laboratory and imaging&#xD;
      test results, reports of surgical procedures or interventions, intraoperative anesthesia&#xD;
      records, post-operative laboratory trends, and postoperative complications were extracted&#xD;
      from the computer-based data management system and prospectively maintained in transplant&#xD;
      databases in both centers. Recipients of LDLT were divided in two groups according to the&#xD;
      presence or absence of PVT.&#xD;
&#xD;
      Portal flow measurements were recorded with VeriQ (Medistim ASA, Oslo, Norway) Doppler&#xD;
      flowmeter device in one of the centers later in the study period.&#xD;
&#xD;
      The follow-up and recordings of the patients were maintained in the outpatient clinics of the&#xD;
      two centers.&#xD;
&#xD;
      The most serious complication experienced by each patient was recorded according to the&#xD;
      Clavien-Dindo classification Primary outcome of the current study was the survival rates of&#xD;
      patients with and without PVT Secondary outcomes of the study included morbidity in patients&#xD;
      with and without PVT after LDLT, risk factors of mortality after LDLT to patients with PVT&#xD;
      and comparison of intraoperative portal flow measurements between patients with and without&#xD;
      PVT&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">October 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>Time (days) from post transplant day1 to post transplant1 year</time_frame>
    <description>Posttransplant survival time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>From posttransplant day1 to post-transplant 30th day</time_frame>
    <description>Highest grade of complication after LDLT according to Dindo-Clavien Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flow</measure>
    <time_frame>Intraoperatively twice: before recipient hepatectomy (portal flow of diseased liver ) and at the end of transplantation procedure</time_frame>
    <description>Intraoperative portal flow measurements (ml/min) of diseased liver and transplanted liver with Doppler flowmeter</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">335</enrollment>
  <condition>Portal Vein Thrombosis</condition>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>PVT</arm_group_label>
    <description>Patients with pretransplant portal vein thrombosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-PVT</arm_group_label>
    <description>Patients without pretransplant portal vein thrombosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>living donor liver transplantation</intervention_name>
    <description>Living donor liver transplantation</description>
    <arm_group_label>PVT</arm_group_label>
    <arm_group_label>non-PVT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thrombectomy or interposition graft</intervention_name>
    <description>Portal flow restoration due to PVT in any manner</description>
    <arm_group_label>PVT</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients that who underwent living donor liver transplantation in the study period in&#xD;
        the two centers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients underwent liver transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric liver transplants&#xD;
&#xD;
          -  Deceased donor liver transplants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elvan O Kirimker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara University</affiliation>
  </overall_official>
  <reference>
    <citation>Conzen KD, Pomfret EA. Liver transplant in patients with portal vein thrombosis: Medical and surgical requirements. Liver Transpl. 2017 Oct;23(S1):S59-S63. doi: 10.1002/lt.24856.</citation>
    <PMID>28834305</PMID>
  </reference>
  <reference>
    <citation>Yerdel MA, Gunson B, Mirza D, Karayalçin K, Olliff S, Buckels J, Mayer D, McMaster P, Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000 May 15;69(9):1873-81.</citation>
    <PMID>10830225</PMID>
  </reference>
  <reference>
    <citation>Ravaioli M, Zanello M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Cucchetti A, Pinna AD. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011 Feb;253(2):378-84. doi: 10.1097/SLA.0b013e318206818b.</citation>
    <PMID>21183851</PMID>
  </reference>
  <reference>
    <citation>Zanetto A, Rodriguez-Kastro KI, Germani G, Ferrarese A, Cillo U, Burra P, Senzolo M. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis. Transpl Int. 2018 Dec;31(12):1318-1329. doi: 10.1111/tri.13353. Epub 2018 Oct 23.</citation>
    <PMID>30230053</PMID>
  </reference>
  <reference>
    <citation>Qi X, Dai J, Jia J, Ren W, Yang M, Li H, Fan D, Guo X. Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies. J Gastrointestin Liver Dis. 2015 Mar;24(1):51-9, 4 p following 59. doi: 10.15403/jgld.2014.1121.qix. Review.</citation>
    <PMID>25822434</PMID>
  </reference>
  <reference>
    <citation>Hibi T, Nishida S, Levi DM, Selvaggi G, Tekin A, Fan J, Ruiz P, Tzakis AG. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg. 2014 Apr;259(4):760-6. doi: 10.1097/SLA.0000000000000252.</citation>
    <PMID>24299686</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>Elvan Onur Kirimker</investigator_full_name>
    <investigator_title>Attending surgeon at Dept of Surgery</investigator_title>
  </responsible_party>
  <keyword>Liver transplantation</keyword>
  <keyword>Portal vein thrombosis</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Doppler flowmeter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

